Phenotyping or Genotyping? It's not Either/Or

Myth: Phenotyping gives real-time, accurate antigen status - why rely on genotyping?

The Issues

Serologic phenotyping observes what’s on the cell surface – the antigens currently expressed on a patient’s red cells. It works beautifully in many settings. But it can be compromised by recent transfusions, autoantibodies, weak antigen expression, lack of available reagents, or for patients undergoing monoclonal antibody therapy.

For example, a recently transfused patient’s phenotype may show donor antigens that don’t reflect their true type. A positive DAT or autoantibody can mask antigen reactivity. And some antigens like Do(a/b) and Di(a/b) lack reliable commercial antisera for phenotyping.

The Bypass

Genotyping bypasses these issues by targeting the gene, not the cell. It can confirm “missing” antigens (like someone who phenotypes Kell-negative but carries a silent K0 gene), clarify weak or partial variants, and provide answers when phenotyping is equivocal or impossible. This is especially useful in oncology patients (who often have donor cells present), in autoimmune hemolytic anemia (where DAT positivity can interfere), or in complex alloimmunization cases.

Complementary, not Competitors

That said, genotyping isn’t infallible – it may miss rare novel mutations not covered by the assay. This is why genotyping and phenotyping are complementary, not competitors. Each has strengths and blind spots. Using both when appropriate ensures the safest possible transfusion decisions. For instance, one might phenotype for common antigens but genotype for those where serology is unreliable (e.g., recent transfusion or variant alleles).

Embrace Both Tools

In practice, the question isn’t “phenotyping or genotyping?” but rather “when do we need more than phenotyping alone?” Embracing both tools ensures real-time accuracy. Together, they let us navigate around challenges like mixed-field results or reagent limitations. The end result is better-informed care – maximizing transfusion safety by not relying on either method alone when a patient’s situation calls for both.